Before, During, and After the First Wave of COVID-19: Mortality Analyses Reveal Relevant Trends in Germany and its States until June 2020

ABSTRACT

Objective Well-established mortality ratio methodology can contribute to a fuller picture of the SARS-CoV-2/COVID-19 burden of disease by revealing trends and informing mitigation strategies. This work examines respective data from Germany by way of example.

Methods Using monthly and weekly all-cause mortality data from January 2016 to June 2020 (published by the German Federal Statistical Institute) for all ages,<65 years and≥65 years, and specified for Germany’s federal states, we explored mortality as sequela of COVID-19. We analysed standardized mortality ratios (SMRs) comparing 2020 with 2016–2019 as reference years with a focus on trend detection.

Results In Germany as a whole, elevated mortality in April (most pronounced for Bavaria) declined in May. The states of Hamburg and Bremen had increased SMRs in all months under study. In Mecklenburg-Western Pomerania, decreased SMRs in January turned monotonically to increased SMRs by June. Irrespective of age group, this trend was pronounced and significant.

Conclusions Increased SMRs in Hamburg and Bremen must be interpreted with caution because of potential upward distortions due to a “catchment bias”. A pronounced excess mortality in April across Germany was confirmed and a hitherto undetected trend of increasing SMRs for Mecklenburg-Western Pomerania was revealed. To meet the pandemic challenge and to benefit from research based on data collected in standardized ways, national authorities should regularly conduct SMR analyses. For independent analyses, national authorities should also expedite publishing raw mortality and population data, including detailed information on age, sex, and cause of death, in the public domain.

Key words

SARS-CoV-2/COVID-19 - SMR - excess mortality - epidemiology - surveillance

Publication History

Article published online:
08 September 2021

• References

• 1 Callaway E, Cyranoski D. China coronavirus: Six questions scientists are asking. Nature 2020; 577: 605-607
• 2 Odone A. et al. The first 10,000 COVID-19 papers in perspective: Are we publishing what we should be publishing?. Eur J Public Health 2020; 30: 849-850
• 3 Leon DA. et al. COVID-19: a need for real-time monitoring of weekly excess deaths. Lancet 2020; 395: e81
• 4 Morfeld P. et al. COVID-19: Spatial resolution of excess mortality in Germany and Italy. J Infect 2021; 27: e12630
• 5 Morfeld P, Erren TC. Deaths in nine regions of Italy in February/March 2020: “Mortality Excess Loupe” for SARS-CoV-2/COVID-19-Epidemiology in Germany. Gesundheitswesen 2020; 82: 400-406
• 6 Morfeld P, Erren TC. Mortality and Attributable Fraction in COVID-19 Analysis: Avoiding Research Waste and Negligence. Am J Public Health 2020; 110: 1644-1645
• 7 Destatis. Sterbefälle - Fallzahlen nach Tagen, Wochen, Monaten, Altersgruppen und Bundesländern für Deutschland 2016–2020. 2020 23.6.2020]; Available from: https://www.destatis.de/DE/Themen/Gesellschaft-Umwelt/Bevoelkerung/Sterbefaelle-Lebenserwartung/Tabellen/sonderauswertung-sterbefaelle.html
• 8 Breslow NE, Day NE. Statistical methods in cancer research. Volume II – The design and analysis of cohort studies. Lyon: International Agency for Research on Cancer; 1987
• 9 Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. 2008. Philadelphia: Lippincott Williams & Wilkins;
• 10 Checkoway H, Pearce N, Kriebel D. Research methods in occupational epidemiology. vol. 34, 2nd ed. 2004. New York: Oxford University Press;
• 11 Armitage P, Berry G. Statistical Methods in Medical Research. 1988. Blackwell Scientific Publications; Oxford: 2nd Edition
• 12 Sutton AJ, Abrams KR, Jones DR. et al. Methods for Meta-analysis in Medical Research. 2000. Wiley; Chichester, U.K:
• 13 Nielsen J. et al. Pooling European all-cause mortality: methodology and findings for the seasons 2008/2009 to 2010/2011. Epidemiol Infect 2013; 141: 1996-2010
• 14 Cameron AC, Trivedi PK. Microeconometrics. Methods and Applications. 2005. New York: Cambridge University Press;
• 15 Cameron AC, Trivedi PK. Microeconometrics using Stata. 2010. A Stata Press Publication, Stata Corp LP; College Station, Texas: Revised Edition
• 16 Stang A. et al. Excess mortality due to COVID-19 in Germany. J Infect 2020; 81: 797-801
• 17 Morfeld P, Timmermann B, Groß JV. et al. COVID-19: Spatial resolution of excess mortality in Germany and Italy. Journal of Infection 2021; 82: 421-422
• 18 Morfeld P, Timmermann B, Groß JV. et al. COVID-19: Wie änderte sich die Sterblichkeit? – Mortalität von Frauen und Männern in Deutschland und seinen Bundesländern bis Oktober 2020 [COVID-19: How did mortality change?. Mortality of women and men in Germany and its federal states until October 2020] Dtsch Med Wochenschr 2021; 146: 129-131
• 19 Morfeld P, Timmermann B, Gross JV. et al. COVID-19: Mortality in Germany 2020 - Reply to the Letter. Dtsch Med Wochenschr 146: 427 2021;
• 20 Morfeld P, Timmermann B, Groß JV. et al. COVID-19: Heterogeneous excess mortality and “burden of disease” in Germany and Italy and their states and regions, January – June 2020. Frontiers in Public Health, section Infectious Diseases – Surveillance, Prevention and Treatment. 2021
• 21 zur Nieden F, Sommer B, Lüken S. Sonderauswertung der Sterbefallzahlen 2020 - Daten zur Einordnung einer zeitweisen Übersterblichkeit im Zusammenhang mit der Corona-Pandemie. Statistisches Bundesamt | WISTA | 4 |. 2020
• 22 Vestergaard LS. et al. Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020. Euro Surveill. 2020 25.
• 23 Erren TC, Morfeld P. COVID-19-Mortalität: Mit viel Sicht fliegen. Dtsch Ärztebl 2020; 117: A-1010 /B-850
• 24 Laufs J. et al. Coronavirus (SARS-CoV-2) – Outbreak in North Rhine-Westphalia (District of Heinsberg) – First diagnosis of a COVID-19 manifestation in a couple. Dtsch Med Wochenschr 2020; 145: 665-669
• 25 (Destatis), S.B. Genesis Database. 2020 24.07.2020/07:17]; Available from https://www-genesis.destatis.de/genesis//online?operation=table&code=12411-0013&bypass=true&levelindex=0&levelid=1598588177483#abreadcrumb
• 26 Hammitt JK. et al. Premature Deaths, Statistical Lives, and Years of Life Lost: Identification, Quantification, and Valuation of Mortality Risks. Risk Anal 2020; 40: 674-695
• 27 Küpke NK. et al. Gesetz für den Schutz vor Masern und zur Stärkung der Impfprävention (Masernschutzgesetz). Epid Bull 2020; 10: 3-5
• 28 network E. Available from https://www.euromomo.eu/
• 29 Lewis P, Erren TC. COVID-19: science must not be the boy who cried wolf. J Epidemiol Community Health 2020; 74: 676
• 30 Yelin D. et al. Long-term consequences of COVID-19: research needs. Lancet Infect Dis 2020; 20: 1115-1117
• 31 Rubino F. et al. New-Onset Diabetes in Covid-19. N Engl J Med 2020; 383: 789-790
• 32 Setti L. et al. Increased incidence of interstitial pneumonia detected on [(18)F]-FDG-PET/CT in asymptomatic cancer patients during COVID-19 pandemic in Lombardy: a casualty or COVID-19 infection? Eur J Nucl Med Mol Imaging. 2020
• 33 Schwartz DA et al. Confirming Vertical Fetal Infection with COVID-19: Neonatal and Pathology Criteria for Early Onset and Transplacental Transmission of SARS-CoV-2 from Infected Pregnant Mothers. Arch Pathol Lab Med 2020; 144: 1451–1456
• 34 Radermacher WJ. Wie Statistiken helfen können – über COVID-19 hinaus. Statistisches Bundesamt | WISTA | 4 | 2020; 23–29
• 35 Everts J. The dashboard pandemic. Dialogues in Human Geography 2020; 10: 260-264
• 36 Johns Hopkins University. COVID-19 Dashboard. 2020 July 11, 2020]; Available from https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6
• 37 Doll R. Introduction and overview. Epidemiology of lung cancer. Lung biology and health and disease. Vol. 74 1994. Marcel Dekker, Inc; New York-Basel-Hong Kong:
• 38 Allebeck P, Wallin AS. In search of the relevant covid research. Eur J Public Health. 2020